Is Lyrica (Pregabalin) Worth It for Fibromyalgia? What the Research Actually Says

The Numbers Your Doctor Probably Did Not Share

Pregabalin (brand name Lyrica) is the most-prescribed medication for fibromyalgia. It has FDA approval. Your rheumatologist or GP has likely mentioned it.

Here is what they probably did not explain: the Number Needed to Treat (NNT).

At 300-450mg/day (the standard therapeutic dose):
- 1 in 3 patients achieve 30% or more pain reduction (NNT = 6)
- 1 in 10 patients achieve 50% or more pain reduction (NNT = 9-11)
- Roughly 1 in 3 patients discontinue due to side effects (NNH = 5-11)

What this means in plain English: if 10 fibromyalgia patients take pregabalin, about 3 will get meaningful relief. About 1 will get substantial relief. And about 3 will stop because the side effects are worse than the benefit.

These are not bad numbers for fibromyalgia treatment, they are among the better medication options available. But they are a long way from the impression most patients have when it is prescribed, which is: "this will help your pain."

The Side Effects Nobody Prepared You For

The most common side effects of pregabalin at therapeutic doses:

Frequently reported (affecting 10-30% of patients):
- Dizziness and lightheadedness
- Somnolence (excessive drowsiness)
- Weight gain (average 2-5kg over 6 months)
- Peripheral oedema (swelling in hands and feet)
- Brain fog and cognitive slowing

Less common but significant:
- Blurred vision
- Dry mouth
- Difficulty concentrating
- Balance problems
- Mood changes

For many fibromyalgia patients who are already battling brain fog, fatigue, and weight concerns, these side effects directly worsen some of the symptoms they are trying to treat.

The withdrawal question: Pregabalin can cause physical dependence. Stopping abruptly after extended use can produce withdrawal symptoms including anxiety, insomnia, pain rebound, and in rare cases, seizures. Tapering under medical supervision is essential.

This does not mean pregabalin is dangerous. It means it should be started with realistic expectations about both benefits and risks.

The Honest Question: Is It Worth It?

Whether pregabalin is worth it depends entirely on your individual response. And unfortunately, you cannot predict your response before trying it.

Pregabalin may be worth trying if:
- You have severe sleep disruption (it can significantly improve sleep quality)
- You have tried non-pharmacological approaches first and need additional support
- Your doctor starts you on a low dose (25-75mg nightly) and titrates slowly
- You treat it as one tool in a broader strategy, not a standalone solution

Pregabalin is likely not worth continuing if:
- Side effects are equal to or worse than the pain it reduces
- You are on a high dose (300-450mg) with minimal benefit after 4-8 weeks
- It is your only treatment (medication alone rarely produces sustained improvement in fibromyalgia)
- The cognitive effects are impacting your daily function

The critical point: Pregabalin works best when combined with exercise, pain neuroscience education, and psychological support. As a standalone treatment, it produces modest effects. As part of a multimodal approach, it can provide the window of reduced pain that allows you to engage with the therapies that produce lasting change.

What the Evidence Says About Alternatives

If pregabalin is not working or the side effects are not acceptable, here is what the evidence supports:

Other medications:
- Duloxetine (Cymbalta): Similar NNT data to pregabalin. Works via serotonin and norepinephrine. Better for patients with co-existing depression. Different side effect profile (nausea, dry mouth).
- Low-dose naltrexone (LDN): 0.5-6mg nightly. Emerging evidence for neuroinflammation reduction. Fewer side effects. Requires compounding pharmacy.
- Amitriptyline (low dose): 10-25mg at bedtime. Long-established for sleep and pain. Cheap and widely available.

Non-pharmacological approaches (often equal or better long-term outcomes):
- Graded aerobic exercise: Strongest evidence of any single intervention for fibromyalgia. Start very low. Progress very slowly.
- Pain neuroscience education: Understanding what drives fibromyalgia reduces threat perception and pain output.
- CBT for chronic pain: Targets catastrophising, fear-avoidance, and sleep disruption.
- Mindfulness-Based Stress Reduction (MBSR): 8-week programs show moderate to large effects on depression and quality of life.

The Tonmya approval (sublingual cyclobenzaprine, August 2025) adds another option for fibromyalgia, specifically targeting sleep disruption.

Making the Decision

If you are currently on pregabalin and wondering whether to continue:
1. Track your pain, sleep, and side effects systematically for 4 weeks
2. Share the data with your prescriber
3. Discuss whether the benefit-to-side-effect ratio is acceptable
4. Consider adding non-drug approaches alongside medication

If you are considering starting pregabalin:
1. Ask your doctor to start low (25-75mg nightly)
2. Set a clear review timeline (4-8 weeks)
3. Define what "success" looks like before starting
4. Begin non-drug approaches simultaneously

No medication is universally right or wrong for fibromyalgia. The question is whether it is right for you, at this dose, as part of this broader strategy.

Whatever you decide, track the data. Decisions made on data are better than decisions made on hope or frustration.